Table 3.
In-cell Western identifies 9 FDA approved drugs efficacious in K562 s and iRBCs.
| Drug Name | K562 | iRBC | Indication |
|---|---|---|---|
| Daunorubicin Hydrochloride | 4.55 | 5.76 | Acute Myeloid Leukemia |
| Epirubicin Hydrochloride | 2.58 | 4.59 | Breast Cancer |
| Pyrimethamine | 2.23 | 2.01 | Malarial Infection |
| Mafenide Acetate | 2.11 | 2.71 | Bacterial Infection |
| Prednisolone | 2.09 | 4.32 | Immunosuppression |
| Quinidine Hydrochloride | 1.99 | 2.08 | Malarial Infection |
| Perphenazine | 1.71 | 5.16 | Schizophrenia |
| Felodipine | 1.62 | 1.96 | Hypertension |
| Duvadilan | 1.60 | 2.58 | Cerebral Vascular Insufficiency |